2001
DOI: 10.1177/108705710100600402
|View full text |Cite
|
Sign up to set email alerts
|

The Integration of High Throughput Technologies for Drug Discovery

Abstract: Producing quality clinical candidates less prone to late stage failure is greatly facilitated by better integration of the relevant high throughput functions and the inclusion of ADME/toxicology further upstream in the discovery process. We describe the tasks and their integration in the context of the design, make and test triad.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2002
2002
2020
2020

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…High throughput or high content screening using fluorescence techniques requires simultaneous illumination of multiple samples, e.g., for drug discovery [31] or for examination of diseases accompanied by altered membrane properties, e.g., Morbus Alzheimer [32], Morbus Crohn [33] or Niemann-Pick disease [34]. For these purposes, we developed a microtiter plate reader system based on multiple TIR excitation and fluorescence detection [35].…”
Section: Tir-readermentioning
confidence: 99%
“…High throughput or high content screening using fluorescence techniques requires simultaneous illumination of multiple samples, e.g., for drug discovery [31] or for examination of diseases accompanied by altered membrane properties, e.g., Morbus Alzheimer [32], Morbus Crohn [33] or Niemann-Pick disease [34]. For these purposes, we developed a microtiter plate reader system based on multiple TIR excitation and fluorescence detection [35].…”
Section: Tir-readermentioning
confidence: 99%